A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic model.
Marie Westwood, Nigel Armstrong, Eline Krijkamp...
https://pubmed.ncbi.nlm.nih.gov/39023142/Actively Recruiting
Led by University of Oxford · Updated on 2026-07-31
250000
Participants Needed
45
Research Sites
N/A
Total Duration
Researchers are conducting the Oxford Risk Factors And Non-Invasive Imaging Study ORFAN, a prospective, multi-centre observational study that includes a diverse group of patients undergoing CT scans. The study aims to develop and validate new biomarkers and image analysis methods related to cardiometabolic and other disease risks by linking imaging data with patient information and clinical outcomes. It will assess the specificity, usefulness, and predictive value of these imaging techniques. Participants include those undergoing coronary CT angiograms CCTA and other CT scans of the chest, abdomen, and pelvis at participating centres. The study collects both new and past CT scans, combining them with blood biomarkers, genetic data, and clinical follow-up information. Some participants will have repeat CCTA scans at least six months apart to observe disease progression. The study involves multiple cohorts, including patients recruited prospectively and those with prior CT scans. During the study, participants will have their CT scans linked with demographic and clinical data, blood samples, and genetic information. Researchers will follow patients over up to 15 years, tracking cardiac and all-cause mortality, non-fatal vascular events, CT scan findings, and disease progression. Additional outcomes include cardiovascular risk factors, hospital admissions, genotyping, and validation of image analysis software. The long-term follow-up allows for extensive monitoring of disease development and outcomes.
CONDITIONS
The Oxford Risk Factors And Non-Invasive Imaging Study
K
Kenneth Chan, Dr
A
Ahmad Abdullrahman, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Oxford
Lead Sponsor
Caristo Diagnostics Limited
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 15 years
Participants undergo CT scans and provide clinical, blood, and genetic data. Some will have repeat CT scans to assess disease progression. Researchers will collect outcomes data and follow participants for up to 15 years.
Follow-up visits as per clinical care and study protocol
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Marie Westwood, Nigel Armstrong, Eline Krijkamp...
https://pubmed.ncbi.nlm.nih.gov/39023142/University of Oxford
Lead Sponsor
Caristo Diagnostics Limited
Collaborating Sponsor